PPT-FUTURA/OASIS-8 Major bleeds/minor bleeds/vascular access site complications at 48 hours:

Death MI or revascularization 45 vs 29 p 006 respectively Stent thrombosis 12 vs 05 p 011 respectively Trial design NSTEMI patients initially treated with fondaparinux

dose heparin inhibitor glycoprotein heparin dose glycoprotein inhibitor iiia iib unfractionated group standard revascularization futura fondaparinux treated initially patients

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/933712" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "FUTURA/OASIS-8 Major bleeds/minor bleeds..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.